Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

bosentan

bosentan
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Tracleer TABLET, ORAL 62.5 mg, 125 mg    


Comments:

Tracleer medication guide


Classified as non-formulary. Automatic interchange for ADULT patients.

Interchange not appropriate for pediatric patients: Inpatients may use home supply of bosentan, or physician to be contacted to discuss alternatives.

ORDERED FORMULATION

THERAPEUTIC INTERCHANGE

bosentan (Tracleer)

  • 62.5 mg oral twice daily
  • 125 mg oral twice daily

macitentan (Opsumit)

  • 10 mg oral once daily
  • 10 mg oral once daily

 

  1. If a new start (male or female), confirm with the Bosentan REMS (1-866-359-2612) that the prescriber is authorized.
  2. If a new start (male or female) verify with the REMS that the patient is enrolled OR verify with the prescriber that the patient will be enrolled prior to discharge and that counseling on pregnancy (for females of reproductive potential) and liver testing has been completed.
  3. For new starts and continuance of home med, verify in all patients that liver testing has been done and that AST/ALT are < 3 x the ULN, and a pregnancy test for females of reproductive potential.
  4. For continuance of home med (male or female), verify patient is enrolled in the REMS, check that AST/ALT are < 3 x ULN, and a pregnancy test for females of reproductive potential.
  5. For all patients, complete a REMS progress note.  A Dispense Authorization # is not needed for inpatient pharmacies.

For Formulary Substitution from bosentan to macitentan for ADULT patients:

  1. If the patient was on bosentan as an outpatient and auto-subbed to macitentan as an inpatient, verify patient enrolled in the bosentan REMS.
  2. For short-term substitution while an inpatient, the patient does NOT need to be enrolled in the macitentan REMS
  3. The prescriber continuing the outpatient medication does NOT need to be an authorized prescriber with the REMS program.

 


Reviewed: April 27, 2005

Updated: June 2020


REMS: View FDA REMS Info


Last updated: Mar. 19, 2024







This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.